Cargando…
Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea
Emerging clinical data indicate that transfusion-dependent patients with bone marrow-failure syndromes (BMFS) are at risk of the consequences of iron overload, including progressive damage to hepatic, endocrine, and cardiac organs. Despite the availability of deferoxamine (DFO) in Korea since 1998,...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer Japan
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516545/ https://www.ncbi.nlm.nih.gov/pubmed/18604581 http://dx.doi.org/10.1007/s12185-008-0117-0 |